期刊文献+

Calphostin C对人视网膜母细胞瘤细胞增殖的抑制作用

Inhibiting effect of Calphostin C on the proliferation of human retinoblastoma oncocytes
下载PDF
导出
摘要 目的探讨Calphostin C对人视网膜母细胞瘤(retinoblastoma,Rb)细胞增殖的抑制作用。方法体外培养人Rb44细胞,MTT法检测不同浓度(0.062 5 nmol·L-1、0.125 0 nmol·L-1、0.250 0 nmol·L-1、0.500 0 nmol·L-1、1.000 0 nmol·L-1)Calphostin C作用不同时间(24 h和48 h)对人Rb44细胞增殖的影响;流式细胞术观察不同浓度(0.062 5 nmol·L-1、0.125 0nmol·L-1、0.250 0 nmol·L-1、0.500 0 nmol·L-1、1.000 0 nmol·L-1)Calphostin C作用不同时间(24 h和48 h)对人Rb44细胞周期及凋亡的影响。结果与对照组相比,Calphostin C对体外培养的人Rb44细胞增殖具有显著的抑制作用,并呈一定的浓度和时间依赖性,1.000 0 nmol·L-1Calphostin C作用48 h对人Rb44细胞增殖的抑制作用最明显,增殖抑制率达(70.23±2.43)%。Calphostin C作用人Rb44细胞24 h和48 h的IC50分别为1.742 nmol·L-1和0.258 nmol·L-1。与对照组人Rb44细胞各个细胞周期分布相比,Calphostin C作用24 h后0.500 0 nmol·L-1组和1.000 0 nmol·L-1组G1期细胞比例升高,G2/M期细胞比例明显减少(P<0.05或P<0.01)。Calphostin C作用人Rb44细胞48 h后0.250 0 nmol·L-1组、0.500 0 nmol·L-1组和1.000 0 nmol·L-1组G2/M期细胞比例与对照组相比也明显减少(P<0.05或P<0.01)。与对照组人Rb44细胞凋亡率相比,除0.062 5 nmol·L-1Calphostin C作用24 h组外,其余各组人Rb44细胞的凋亡率均显著升高,差异均有统计学意义(P<0.05或P<0.01),且随着Calphostin C浓度的增加,细胞凋亡率增高,呈一定的剂量依赖性。结论 Calphostin C对Rb细胞的体外增殖具有一定的抑制作用,同时对细胞凋亡起着促进作用,能够阻滞细胞周期进程。 Objective To explore the inhibiting effect of Calphostin C on the proliferation of human retinoblastoma (Rb) cells. Methods Human Rb44 cells were cultivated in vitro. MTT and flow cytometry (FCM) were performed respectively to measure the influence of Calphostin C(0.052 5 nmol ·L^-1 ,0. 125 0 nmol ·L^-1 ,0.250 0 nmol ·L^-1 ,0.500 0 nmol·L^-1,1. 000 0 nmol ·L^-1 ) on the proliferation of human Rb44 cells after different action time(24 hours,48 hours). Results Compared with the con- trol, Calphostin C was of great inhibiting effect on the proliferation human Rb44 cells in a certain concentration-and time-dependent manner. Calphostin C( 1. 000 0 nmol · L^-1 ) with an action time of 48 hours had the strongest inhibiting effect, the proliferation inhi- bition rate was (70.23 + 2.43 ) %. Calphostin C IC50 on human Rb44 cells were 1. 742 nmol ·L^-1 and 0.258 nmol ·L^-1 when action time were 24 hours and 48 hours reapec- tively. Compared with distribution of cell cycles of the control, the proportion of G1 phase cells increased, while that of the G2/M phase cells decreased significantly in Cal- phostin C groups (0. 500 0 nmol ·L^-1, 1. 000 0 nmol ·L^-1 ) with an action time of 24 hours(P 〈 0. 05 or P 〈 0.01 ). G2/M cells in Calphostin C groups(0. 250 0 nmol ·L^-1, 0. 500 0 umol ·L^-1,1. 000 0 umol ·L^-1 ) with an action time of 48 hours were less thanthat of the control(P 〈 0.05 or P 〈 0.01 ). Apoptosis rate of human Rb44 cells of all groups were significantly higher than that of the control, except for the Calphostin C group (0.052 5 nmol ·L^-1 ) with an action time of 24 hours (P 〈 0.05 or P 〈 0.01 ). The apoptosis rate increased with the rise of Calphostin C concentration, which showed a certain dose-dependent manner. Conclusion Calphostin C has a certain inhibiting effect on the proliferation of human Rb cells in vitro, and it could promote human Rb cell apoptosis and impede the process of cell cycles.
出处 《眼科新进展》 CAS 北大核心 2013年第9期829-831,842,共4页 Recent Advances in Ophthalmology
关键词 视网膜母细胞瘤 Calphostin C 细胞增殖 细胞凋亡 retinoblastoma Calphostin C cell proliferation apoptosis
  • 相关文献

参考文献16

  • 1Mustafa MM, Jamshed A, Khafaga Y, Mourad WA, A1-Mesfer S, Kofide A, et al. Adjuvant chemotherapy with vincristine, doxoru- bicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma [ J ]. J Pediatr Hematol Oncol, 1999,21 (5) :364-369.
  • 2Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Ca- ter J, et al. Postenucleation adjuvant therapy in high-risk retino- blastoma [ J ]. Arch Ophthalmol, 2002,120 ( 7 ) : 923 -931.
  • 3Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al. Chemoreduction plus focal therapy for retinoblas- toma: factors predictive of need for treatment with external beam radiotherapy or enucleation [J]. Am J Ophthalmol, 2002, 133 (5) :657-664.
  • 4Kiratli H, Bilgi- S, Ozerdem U. Retinoblastoma with acute lym- phoblastic leukemia, polyposis coli, and multiple hamartomas [J]. JAAPOS,1998,2(5) :385-385.
  • 5Shields CL, Shields JA. Recent developments in the management of retinoblastoma [ J ]. J Pediatr Ophthalmol Strabismus, 1999, 36(1) :8-18.
  • 6Au CM, Luk SK, Jackson C J, Ng HK, Yow CM, To SS. Differential effects of photofrin, 5-aminole-vulinic acid and calphostin C on glioma cells[J]. J Photochem Photobiol,2006,85( 1 ) :92-101.
  • 7Maxhimer JB, Reddy RM, Zuo J, Cole GW, Schrump DS, Nguyen DM. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor ( trichostatin A) and protein kinase C inhibitor ( calphostin C ) [ J]. J Thorac Cardiovasc Surg,2005,129 ( 1 ) :53-53.
  • 8Walsh MF, Woo RK, Gomez R, Basson MD. Extracellular pres- sure stimulates colon cancer cell proliferation via a mechanism requiring PKC and tyrosine kinase signals [ J ]. Cell Prolif, 2004, 37 (3) :427-441.
  • 9Chabannes E, Fauconnet S, Bernardini S, Wauerand H, Adessi G, Bittard H. Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells [ J ]. Cell Signal, 2001,13 ( 6 ) :585-591.
  • 10Rosfjord EC, Maemura M, Johnson MD, Torri JA, Akiyama SK, Woods VL Jr, et al. Activation of protein kinase C by phorbolest- ers modulates alpha2 betal integrin on MCF-7 breast cancer cells [ J ]. Exp Cell Res, 1999,248 ( 2 ) : 250-271.

二级参考文献10

  • 1ZHU Y,DONG Q,TAN BJ,et al.The PKCalpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals[J].Cancer Res,2005,65(11):4520-4524.
  • 2CAMERON AJ,PROCYK KJ,LEITGES M,et al.PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival[J].Int J Cancer,2008,123(4):769-779.
  • 3TUTTLE KR,ANDERBERG RJ,COONEY SK,et al.Oxidative stress mediates protein kinase c activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet[J].Am J Nephrol,2008,29(3):171-180.
  • 4KOBAYASHI E,NAKANO H,MORIMOTO M,et al.Calphostin C (UCN-1028C),a novel microbial compound,is a highly potent and specific inhibitor of protein kinase C[J].Biochem Biophys Res Commun,1989,159(2):548-553.
  • 5PARKIN DM,BRAY F,FERLAY J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 6萨姆布鲁克 J,拉塞尔 DW.分子克隆实验指南[M].第3版.北京:科学出版社,2002:1713-1726.
  • 7MADDIKA S,ANDE SR,PANIGRAHI S,et al.Cell survival,cell death and cell cycle pathways are interconnected:implications for cancer therapy[J].Drug Resist Updat,2007,10(1-2):13-29.
  • 8KIM E,GIESE A,DEPPERT W.Wild-type p53 in cancer cells:when a guardian turns into a blackguard[J].Biochem Pharmacol,2009,77(1):11-20.
  • 9ABUKHDEIR AM,PARK BH.P21 and p27:roles in carcinogenesis and drug resistance[J].Expert Rev Mol Med,2008,10:e19.
  • 10HARPER JW,ADAMI GR,WEI N,et al.The p21Cdk-interacting protein Cipl is a protent inhibition of G1 cyclin-dependent kinases[J].Cell,1993,75(4):805-816.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部